Multifunctional molecule directed against cd28
US-2026049141-A1 · Feb 19, 2026 · US
Ose Immunotherapeutics holds 92 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 92 |
| Recent patents | 38 |
| First publication | Sep 20, 2016 |
| Latest publication | Feb 19, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026049141-A1 · Feb 19, 2026 · US
US-2026035434-A1 · Feb 5, 2026 · US
US-12534533-B2 · Jan 27, 2026 · US
US-2025340632-A1 · Nov 6, 2025 · US
US-12448454-B2 · Oct 21, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026049141-A1 · Feb 19, 2026 · US
US-2026035434-A1 · Feb 5, 2026 · US
US-12534533-B2 · Jan 27, 2026 · US
US-2025340632-A1 · Nov 6, 2025 · US
US-12448454-B2 · Oct 21, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 88 |
| Chemistry & Metallurgy | 88 |
| Physics | 21 |
| Cross-Sectional Technologies | 7 |
Answers are generated from the same data shown on this page.